David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, Clinical Pharmacist Specialist in Infectious Diseases/HIV at Temple University Hospital (TUH), and T. Sam Albanesi, MD, Infectious Diseases Fellow at TUH, wrote an article for Contagion Live about lenacapavir, a new antiretroviral for the treatment of multi-drug resistant HIV-1 infection.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH